Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INBX | AMGN | VRTX | REGN | GSK |
| Company | Inhibrx Biosciences Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 16.32 | 317.69 | 471.58 | 875.00 | 36.27 |
| High | 16.34 | 323.40 | 477.70 | 883.15 | 37.01 |
| Low | 16.00 | 315.65 | 468.98 | 815.99 | 36.07 |
| Last | 16.03 | 320.16 | 475.98 | 838.20 | 36.76 |
| Change | -0.26 | +4.62 | +0.90 | -84.59 | -0.25 |
| % Change | -1.60% | +1.46% | +0.19% | -9.17% | -0.68% |
| Volume | 35,200 | 2,712,000 | 1,375,000 | 2,291,400 | 12,121,306 |
| 20-Day Average Volume | 60,215 | 1,661,695 | 1,007,260 | 768,415 | 6,413,615 |
| Previous Close | 16.29 | 315.54 | 475.08 | 922.79 | 37.01 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.73 | 319.69 | 474.86 | 970.99 | 38.39 |
| 20-Day Raw Stochastic | 57.83% | 51.40% | 55.03% | 10.66% | 12.04% |
| 20-Day Relative Strength | 54.43% | 48.61% | 50.78% | 17.74% | 34.83% |
| Weighted Alpha | N/A | +16.64 | +23.85 | -10.17 | -2.22 |
| Today's Opinion | N/A | 24% Buy | 56% Buy | 56% Sell | 88% Sell |
| Previous Opinion | N/A | 8% Buy | 40% Buy | 56% Sell | 88% Sell |
| Last Month's Opinion | N/A | 24% Buy | 8% Buy | 24% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.29% since 10/24/24 | +1.42% since 10/24/24 | +0.86% since 10/24/24 | -9.76% since 10/24/24 | -2.60% since 10/24/24 |
| Low | 15.34 on 10/25/24 | 310.63 on 10/30/24 | 468.47 on 10/30/24 | 815.99 on 10/31/24 | 36.07 on 10/31/24 |
| High | 16.43 on 10/30/24 | 323.40 on 10/31/24 | 480.41 on 10/25/24 | 943.83 on 10/25/24 | 38.26 on 10/29/24 |
| 1-Month | |||||
| %Chg | +2.36% since 09/30/24 | -0.64% since 09/30/24 | +2.34% since 09/30/24 | -20.27% since 09/30/24 | -10.08% since 09/30/24 |
| Low | 14.67 on 10/04/24 | 310.63 on 10/30/24 | 447.70 on 10/07/24 | 815.99 on 10/31/24 | 36.07 on 10/31/24 |
| High | 17.02 on 10/17/24 | 329.17 on 10/11/24 | 499.09 on 10/17/24 | 1,061.60 on 10/01/24 | 41.80 on 10/09/24 |
| 3-Month | |||||
| %Chg | +12.25% since 07/30/24 | -3.94% since 07/30/24 | -5.30% since 07/30/24 | -22.23% since 07/30/24 | -7.57% since 07/30/24 |
| Low | 10.80 on 08/12/24 | 306.59 on 08/07/24 | 447.70 on 10/07/24 | 815.99 on 10/31/24 | 36.07 on 10/31/24 |
| High | 17.79 on 09/17/24 | 340.89 on 08/01/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 44.67 on 08/27/24 |
| 6-Month | |||||
| %Chg | N/A since 05/31/24 | +16.87% since 04/30/24 | +21.17% since 04/30/24 | -5.89% since 04/30/24 | -11.29% since 04/30/24 |
| Low | 10.80 on 08/12/24 | 273.38 on 05/01/24 | 392.47 on 05/01/24 | 815.99 on 10/31/24 | 36.07 on 10/31/24 |
| High | 18.95 on 06/05/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 235,814 | 169,548,800 | 122,619,088 | 101,723,752 | 76,704,848 |
| Shares Outstanding, K | 14,476 | 537,329 | 258,102 | 110,235 | 2,072,544 |
| Annual Sales | 1,630,000 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -154,960,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 100,000 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 9,950,400,000 |
| Last Quarter Net Income | 1,858,010,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,480,440,000 |
| 60-Month Beta | N/A | 0.61 | 0.40 | 0.12 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | 125.48 on 08/13/24 | 5.58 on 10/30/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 0.50 on 10/30/24 |
| Latest Earnings Date | 11/12/24 | 10/30/24 | 11/04/24 | 10/31/24 | 10/30/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.385 on 08/16/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | N/A | 08/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.99 | 0.00 | 24.14 | 9.18 |